Any hereditary breast ovarian cancer syndrome in which the cause of the disease is a mutation in the BRCA1 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
The documentation surrounding breast-ovarian cancer, familial, susceptibility to, 1, is limited due to the multifactorial nature of the condition and the variability in clinical presentation among affected individuals. Additionally, the prevalence of this condition is not well characterized, which hampers systematic studies and comprehensive clinical data collection. This can be frustrating, but ongoing research aims to improve understanding and management of this condition.
To navigate your care effectively, consider seeking a genetic counselor who specializes in hereditary cancers. They can provide personalized risk assessments and discuss genetic testing options. Additionally, you may want to connect with a medical oncologist with expertise in breast and ovarian cancers. While there are currently no patient organizations specifically identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable support and information.
Currently, there is one active clinical trial related to breast-ovarian cancer, familial, susceptibility to, 1. You can explore the details and eligibility criteria for this trial by visiting ClinicalTrials.gov at the following link: https://clinicaltrials.gov/search?cond=breast-ovarian%20cancer%2C%20familial%2C%20susceptibility%20to%2C%201. Engaging in clinical trials may provide access to new therapies and contribute to advancing research in this area.
Actionable guidance for navigating care for breast-ovarian cancer, familial, susceptibility to, 1
To navigate your care effectively, consider seeking a genetic counselor who specializes in hereditary cancers. They can provide personalized risk assessments and discuss genetic testing options. Additionally, you may want to connect with a medical oncologist with expertise in breast and ovarian cancers. While there are currently no patient organizations specifically identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable support and information.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.